All the information you need about GB PHARMA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-03-25 | Partially confidential | 2021-12-31 | Complete |
| 2021-04-21 | Partially confidential | 2020-12-31 | Complete |
| 2020-07-07 | Partially confidential | 2019-12-31 | Complete |
| 2019-08-05 | Public | 2018-12-31 | Complete |
| 2018-08-28 | Public | 2017-12-31 | Complete |
| 2017-09-11 | Public | 2016-12-31 | Complete |
| Name | GB PHARMA |
| Siren | 384327953 |
| Closing | 2021-12-31 |
| Registry code | 9712 |
| Registration number | B2022/001256 |
| Management number | 1992B00004 |
| Activity code | 4618Z |
| Closing date n-1 | 2020-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2022-03-25 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 97190 LE GOSIER |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AJ Other Intangible Assets | 3 399.00 | 3 399.00 | 3 399.00 | |
AP Buildings | 400 000.00 | 291 667.00 | 108 333.00 | 400 000.00 |
AR Technical installations, industrial equipment and tools | ||||
AT Other tangible assets | 57 155.00 | 38 523.00 | 18 632.00 | 57 155.00 |
BJ TOTAL (I) | 460 554.00 | 333 589.00 | 126 965.00 | 460 554.00 |
BT Goods | 214 043.00 | 51 759.00 | 162 284.00 | 214 043.00 |
BV Advances and down payments on orders | 3 778.00 | 3 778.00 | 3 778.00 | |
BX Customers and related accounts | 455 582.00 | 455 582.00 | 455 582.00 | |
BZ Other receivables | 33 710.00 | 33 710.00 | 33 710.00 | |
CD Marketable securities | 112 777.00 | 112 777.00 | 112 777.00 | |
CF Cash and cash equivalents | 1 198 031.00 | 1 198 031.00 | 1 198 031.00 | |
CH Prepaid expenses | 2 834.00 | 2 834.00 | 2 834.00 | |
CJ TOTAL (II) | 2 020 755.00 | 51 759.00 | 1 968 996.00 | 2 020 755.00 |
CO Grand total (0 to V) | 2 481 310.00 | 385 348.00 | 2 095 962.00 | 2 481 310.00 |
CS Evaluated investments - equity method | ||||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 40 000.00 | 40 000.00 | 40 000.00 | |
DD Legal reserve (1) | 4 000.00 | 4 000.00 | 4 000.00 | |
DG Other reserves | 1 558 654.00 | 1 414 914.00 | 1 558 654.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 212 260.00 | 273 741.00 | 212 260.00 | |
DL TOTAL (I) | 1 814 916.00 | 1 732 654.00 | 1 814 916.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 2 717.00 | 1 995.00 | 2 717.00 | |
DW Advances and down payments received on current orders | 13 600.00 | 13 600.00 | ||
DX Trade payables and related accounts | 193 536.00 | 203 676.00 | 193 536.00 | |
DY Tax and social security liabilities | 66 959.00 | 101 427.00 | 66 959.00 | |
EA Other liabilities | 4 235.00 | 155 912.00 | 4 235.00 | |
EC TOTAL (IV) | 281 047.00 | 463 000.00 | 281 047.00 | |
EE Grand total (I to V) | 2 095 963.00 | 2 195 655.00 | 2 095 963.00 | |
